Results for tag: "Delta Antagonist"

The Delta Antagonist market is a subset of the Addiction Disorders Drugs market, focusing on drugs that act as antagonists to the delta opioid receptor. These drugs are used to treat opioid addiction, as well as other substance use disorders. Delta antagonists are thought to reduce the rewarding effects of opioids, making them less desirable to the user. They also reduce the risk of relapse and can help to reduce cravings. The Delta Antagonist market is a growing field, with many companies developing new drugs and treatments. Some of the major players in the market include Alkermes, Indivior, Orexo, and Supernus Pharmaceuticals. Other companies such as Allergan, Endo Pharmaceuticals, and Purdue Pharma are also involved in the development of delta antagonist drugs. Show Less Read more